Xponance’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Buy |
27,799
+7,655
| +38% | +$38.7K | ﹤0.01% | 1373 |
|
|
2025
Q1 | $107K | Buy |
20,144
+981
| +5% | +$5.19K | ﹤0.01% | 1339 |
|
|
2024
Q4 | $130K | Buy |
19,163
+3,480
| +22% | +$23.5K | ﹤0.01% | 1337 |
|
|
2024
Q3 | $103K | Buy |
15,683
+2,551
| +19% | +$16.8K | ﹤0.01% | 1318 |
|
|
2024
Q2 | $98.5K | Buy |
+13,132
| New | +$98.5K | ﹤0.01% | 1240 |
|